000			01886 a2200541 4500
005			20250515070821.0
264		0	_c20071127
008			200711s 0 0 eng d
022			_a1083-7159
024	7		_a10.1634/theoncologist.12-5-584 _2doi
040			_aNLM _beng _cNLM
100	1		_aBoccia, Ralph
245	0	0	_aThe effectiveness of darbepoetin alfa administered every 3 weeks on hematologic outcomes and quality of life in older patients with chemotherapy-induced anemia. _h[electronic resource]
260			_bThe oncologist _cMay 2007
300			_a584-93 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aActivities of Daily Living
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnemia _xblood
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aBiomarkers _xblood
650	0	4	_aDarbepoetin alfa
650	0	4	_aDrug Administration Schedule
650	0	4	_aErythrocyte Transfusion
650	0	4	_aErythropoietin _xadministration & dosage
650	0	4	_aFatigue _xchemically induced
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHematinics _xadministration & dosage
650	0	4	_aHemoglobins _xdrug effects
650	0	4	_aHumans
650	0	4	_aKarnofsky Performance Status
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aQuality of Life
650	0	4	_aResearch Design
650	0	4	_aSurveys and Questionnaires
650	0	4	_aTreatment Outcome
700	1		_aLillie, Tom
700	1		_aTomita, Dianne
700	1		_aBalducci, Lodovico
773	0		_tThe oncologist _gvol. 12 _gno. 5 _gp. 584-93
856	4	0	_uhttps://doi.org/10.1634/theoncologist.12-5-584 _zAvailable from publisher's website
999			_c17065802 _d17065802